Zepzelca
Chemical Name | lurbinectedin |
Dosage Form | Injection (intravenous; 4 mg) |
Drug Class | Alkylating agents |
System | Respiratory |
Company | Pharma Mar |
Approval Year | 2020 |
Indication
- Indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.